CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)
Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –
CareDx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
CareDx's free cash flow for the twelve months ending Sep 30, 2019 was -$1.62M. For fiscal 2018 it was -$6.04M. The highest annual figure on record is -$644.00K in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -$6.04M | – |
| FY2017 | Dec 31, 2017 | -$14.49M | – |
| FY2016 | Dec 31, 2016 | -$17.07M | – |
| FY2015 | Dec 31, 2015 | -$10.95M | – |
| FY2014 | Dec 31, 2014 | -$4.08M | – |
| FY2013 | Dec 31, 2013 | -$644.00K | – |
| FY2012 | Dec 31, 2012 | -$1.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.10M | +24.9% |
| Q2 FY2026 | Jun 30, 2026 | $28.75M | – |
| Q1 FY2026 | Mar 31, 2026 | $514.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $36.05M | +418.7% |
| Q2 FY2025 | Jun 30, 2025 | $8.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$28.21M | -1531.5% |
| Q3 FY2021 | Sep 30, 2021 | -$3.24M | -114.5% |
| Q2 FY2021 | Jun 30, 2021 | $6.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$34.88M | -17895.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.97M | -44.6% |
| Q2 FY2020 | Jun 30, 2020 | $22.37M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.76M | -558.5% |
| Q3 FY2019 | Sep 30, 2019 | $196.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $3.56M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.41M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.04M | – |
| Q3 FY2018 | Sep 30, 2018 | -$215.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.29M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.23M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.22M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.81M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.98M | – |
See a number that looks wrong?